The natural history of untreated small (

Neurosurg Rev. 2026 Sep 29;49(1):590. doi: 10.1007/s10143-026-04507-3.ABSTRACTThe clinical management of small, unruptured intracranial aneurysms, particularly those measuring less than 5 mm, represents a significant area of debate in neurovascular surgery. The decision to pursue invasive treatment

Fixed-dose combination versus multi-pill combination antihypertensive therapy in medication-defined apparent treatment-resistant hypertension: real-world evidence on healthcare utilization and health-related quality of life

Front Pharmacol. 2026 Sep 11;17:1903129. doi: 10.3389/fphar.2026.1903129. eCollection 2026.ABSTRACTBACKGROUND: Fixed-dose combination (FDC) antihypertensive therapy is recommended by hypertension guidelines to improve adherence and blood pressure control. However, its association with healthcare uti

Treatment-resistant hypertension in the primary care setting

J Osteopath Med. 2026 Sep 22. doi: 10.1515/jom-2026-0011. Online ahead of print.ABSTRACTCONTEXT: Rates of treatment-resistant hypertension in the United States are increasing despite our better understanding of underlying mechanisms, lifestyle and pharmacologic approaches, and with refinement of tre

Systematic review and network meta-analysis for the 2026 update of the evidence-based clinical practice guidelines for the management with immunosuppressive therapies and biologic agents of membranous nephropathy

Clin Exp Nephrol. 2026 Sep 19. doi: 10.1007/s10157-026-02944-4. Online ahead of print.ABSTRACTBACKGROUND: Multiple immunosuppressive therapies are used to induce remission in membranous nephropathy, but differences in study populations, treatment regimens, and outcome definitions complicate comparis